We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Amy Abernethy, the FDA’s principal deputy commissioner and acting chief information officer, will depart from the agency in a matter of weeks, according to acting commissioner Janet Woodcock.